| Sign In to gain access to subscriptions and/or personal tools. |
An investigation of new toxicity test method performance in validation studies: 3. sensitivity and specificity are not independent of prevalence or distribution of toxicityGillette Environment, Health & Safety, Needham, Massachusetts, USA; leon_bruner{at}gillette.com
The Procter & Gamble Company, Miami Valley Laboratories, Cincinnati, Ohio, USA
Institute for In Vitro Sciences, Gaithersburg, Maryland, USA Often, the only measures of toxicity test performance provided in validation studies are the contingent probability statistics (CPS) sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV). Sensitivity and specificity are generally used in preference to NPV and PPV since NPV and PPV are assumed to vary with changes in prevalence while sensitivity and specificity are assumed to be independent of changes in prevalence. The purpose of the studies reported here was to test whether or not sensitivity and specificity are actually independent of changes in prevalence. Results derived from these studies indicate that sensitivity and specificity vary significantly depending on the prevalence of toxic substances in the set of chemicals being tested. This means sensitivity and specificity should not always be considered constant indicators of toxicity test performance.
Key Words: correlation negative predictive value positive predictive value prediction interval prevalence sensitivity specificity toxicity test performance measurement toxicity test validation validation
Human & Experimental Toxicology, Vol. 21, No. 6,
325-334 (2002) This article has been cited by other articles:
|
|||||||||||||||
